more_reports

The Latest Nutraceuticals Articles from Streetwise Reports

Cannabis Producer Moves to the TSX as Analyst Flags Major Expansion Potential

  ()
Cannara Biotech Inc. (LOVE:TSX; LOVFF:OTCQX; BCB0:FSE) began trading on the Toronto Stock Exchange on March 2 after graduating from the TSX Venture Exchange. Atrium Research initiated coverage with a BUY rating and CA$3.00 target, citing best-in-class EBITDA margins of 29%.
Tags: NutraceuticalsBiotechnology / Pharmaceuticals

Showing Results: 1 to 1 of 1